Latest Period
Q2 2026
Security Snapshot
Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI) Institutional Ownership
CUSIP: 142152107
13F Institutional Holders and Ownership History from Q2 2025 to Q2 2026
Institutions Reporting
245
Shares (Excl. Options)
153,734,822
Price
$17.82
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- CAI on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 153,734,822
- Total 13F value
- $2,742,999,833
- Portfolio coverage rank
- 0.02%
- Share change
- -3,763,590
- Value change
- -$65,630,792
- Number of holders
- 245
- Shares outstanding
- 281,415,375
- SEC-reported price per share
- $16.09
- Insider filing price
- $16.09
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CAI - Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 142152107.
- 245 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 200 to 245 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,797,623,495 to $2,742,999,833.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 245 institutions filings for Q2 2026.
Security key
142152107
Latest holder period
Q2 2026
13F holders
245
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
CAI full holder history
Caris Life Sciences, Inc. SEC filings
Caris Life Sciences, Inc. company facts
Caris Life Sciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 142152107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
CAI
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| HALBERT DAVID D | 44% | $3,311,265,907 | 124,906,296 | David D. Halbert | 30 Jun 2025 | |||
| FMR LLC | 11% | +116% | $547,689,677 | +$294,800,519 | 30,631,585 | +117% | FMR LLC | 31 Mar 2026 |
| J H Whitney VI L P | 4% | -36% | $211,061,531 | -$131,250,000 | 11,256,615 | -38% | J H Whitney VI L P | 30 Jun 2026 |
| TSSP Sub-Fund HoldCo LLC | 2.6% | -50% | $137,382,019 | -$132,344,212 | 7,327,041 | -49% | Alan Waxman | 30 Jun 2026 |
| RIVERVIEW GROUP LLC | 1.3% | 3,583,100 | Millennium Management LLC | 17 Jun 2025 |
As of 30 Jun 2026, 245 institutional investors reported holding 153,734,822 shares of Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI). This represents 55% of the company’s total 281,415,375 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
46%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 11% | 30,923,878 | +0.45% | 0.02% | $551,063,502 |
| J. H. Whitney Equity Partners VI, LLC | 4% | 11,256,615 | -38% | 100% | $200,592,879 |
| COATUE MANAGEMENT LLC | 3.5% | 9,819,992 | 0% | 0.36% | $174,992,258 |
| BRAIDWELL LP | 2.9% | 8,256,032 | +3.1% | 5.4% | $147,122,490 |
| Sixth Street Partners Management Company, L.P. | 2.6% | 7,327,041 | -49% | 23% | $130,567,870 |
| PointState Capital LP | 2.4% | 6,828,835 | -7.2% | 2.1% | $121,689,840 |
| JPMORGAN CHASE & CO | 2.3% | 6,558,514 | +90% | 0.01% | $120,243,533 |
| BlackRock, Inc. | 2% | 5,536,798 | +14% | 0% | $98,665,739 |
| T. Rowe Price Investment Management, Inc. | 1.8% | 5,079,141 | -9.1% | 0.06% | $90,511,000 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.7% | 4,844,431 | +29% | 0% | $86,327,760 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.5% | 4,280,238 | +29% | 0% | $76,273,841 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 1.4% | 3,958,531 | +73% | 0.26% | $70,541,023 |
| NEUBERGER BERMAN GROUP LLC | 1.3% | 3,590,963 | +0.01% | 0.04% | $63,990,963 |
| ORBIMED ADVISORS LLC | 1% | 2,806,811 | 0% | 0.95% | $50,017,372 |
| BNP PARIBAS FINANCIAL MARKETS | 0.84% | 2,370,268 | 0% | 0.02% | $42,238,176 |
| MILLENNIUM MANAGEMENT LLC | 0.78% | 2,202,647 | +44% | 0.03% | $39,251,170 |
| MAK CAPITAL ONE LLC | 0.69% | 1,937,229 | 4.8% | $34,521,421 | |
| MORGAN STANLEY | 0.69% | 1,935,531 | +79% | 0% | $34,491,180 |
| Duquesne Family Office LLC | 0.67% | 1,894,450 | 0% | 0.78% | $33,759,000 |
| Clearbridge Investments, LLC | 0.57% | 1,595,877 | +2.8% | 0.02% | $28,438,525 |
| FIL Ltd | 0.55% | 1,548,918 | +0.18% | 0.02% | $27,601,719 |
| UBS Group AG | 0.51% | 1,423,371 | -48% | 0% | $25,364,471 |
| HRT FINANCIAL LP | 0.5% | 1,418,392 | 0.05% | $25,275,000 | |
| CANADA PENSION PLAN INVESTMENT BOARD | 0.49% | 1,374,952 | +3.9% | 0.01% | $24,501,645 |
| Amundi | 0.43% | 1,218,364 | +5709% | 0.01% | $21,711,246 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Latest
Q2 2026
Rows shown
1-5 of 5
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 153,734,822 | $2,742,999,833 | -$65,630,792 | $17.82 | 245 |
| 2026 Q1 | 156,665,947 | $2,797,623,495 | -$13,711,338 | $17.88 | 200 |
| 2025 Q4 | 145,171,924 | $3,916,731,528 | +$281,575,305 | $26.98 | 184 |
| 2025 Q3 | 113,389,372 | $3,407,348,453 | +$143,025,542 | $30.25 | 137 |
| 2025 Q2 | 109,280,872 | $2,919,429,193 | +$2,917,131,273 | $26.72 | 115 |